NOMURA HOLDINGS INC-SPON ADR (NMR) Stock Fundamental Analysis
USA - NYSE:NMR - US65535H2085 - ADR
7.09 USD
+0.02 (+0.28%)
Overall NMR gets a fundamental rating of 3 out of 10. We evaluated NMR against 235 industry peers in the Capital Markets industry. NMR may be in some trouble as it scores bad on both profitability and health. NMR is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year NMR was profitable.
In the past year NMR has reported a negative cash flow from operations.
NMR had positive earnings in each of the past 5 years.
In multiple years NMR reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.60%, NMR is doing worse than 69.79% of the companies in the same industry.
The Return On Equity of NMR (9.82%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 0.63%, NMR is not doing good in the industry: 70.21% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for NMR is significantly below the industry average of 7.61%.
The last Return On Invested Capital (0.63%) for NMR is above the 3 year average (0.42%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.6% | ||
| ROE | 9.82% | ||
| ROIC | 0.63% |
ROA(3y)0.36%
ROA(5y)0.36%
ROE(3y)5.9%
ROE(5y)5.66%
ROIC(3y)0.42%
ROIC(5y)0.41%
1.3 Margins
NMR's Profit Margin of 7.19% is on the low side compared to the rest of the industry. NMR is outperformed by 63.40% of its industry peers.
In the last couple of years the Profit Margin of NMR has declined.
Looking at the Operating Margin, with a value of 9.96%, NMR is doing worse than 67.23% of the companies in the same industry.
NMR's Operating Margin has declined in the last couple of years.
NMR has a Gross Margin (39.95%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NMR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.96% | ||
| PM (TTM) | 7.19% | ||
| GM | 39.95% |
OM growth 3Y-11.17%
OM growth 5Y-4.76%
PM growth 3Y-7.1%
PM growth 5Y-8.33%
GM growth 3Y-22.42%
GM growth 5Y-9.54%
2. Health
2.1 Basic Checks
Compared to 1 year ago, NMR has less shares outstanding
NMR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for NMR has been reduced compared to a year ago.
2.2 Solvency
NMR has an Altman-Z score of -0.27. This is a bad value and indicates that NMR is not financially healthy and even has some risk of bankruptcy.
NMR's Altman-Z score of -0.27 is on the low side compared to the rest of the industry. NMR is outperformed by 78.72% of its industry peers.
A Debt/Equity ratio of 10.44 is on the high side and indicates that NMR has dependencies on debt financing.
The Debt to Equity ratio of NMR (10.44) is worse than 89.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 10.44 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.27 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
NMR has a Current Ratio of 0.22. This is a bad value and indicates that NMR is not financially healthy enough and could expect problems in meeting its short term obligations.
NMR's Current ratio of 0.22 is on the low side compared to the rest of the industry. NMR is outperformed by 88.09% of its industry peers.
A Quick Ratio of 0.22 indicates that NMR may have some problems paying its short term obligations.
NMR's Quick ratio of 0.22 is on the low side compared to the rest of the industry. NMR is outperformed by 87.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.22 | ||
| Quick Ratio | 0.22 |
3. Growth
3.1 Past
NMR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.74%, which is quite impressive.
The Earnings Per Share has been growing by 10.96% on average over the past years. This is quite good.
Looking at the last year, NMR shows a quite strong growth in Revenue. The Revenue has grown by 13.94% in the last year.
NMR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.39% yearly.
EPS 1Y (TTM)36.74%
EPS 3Y34.65%
EPS 5Y10.96%
EPS Q2Q%-0.58%
Revenue 1Y (TTM)13.94%
Revenue growth 3Y43.77%
Revenue growth 5Y19.39%
Sales Q2Q%-6.17%
3.2 Future
NMR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.45% yearly.
NMR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -6.34% yearly.
EPS Next Y-2.38%
EPS Next 2Y0.42%
EPS Next 3Y1.45%
EPS Next 5YN/A
Revenue Next Year-22.11%
Revenue Next 2Y-10.98%
Revenue Next 3Y-6.34%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.06 indicates a reasonable valuation of NMR.
80.00% of the companies in the same industry are more expensive than NMR, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of NMR to the average of the S&P500 Index (26.76), we can say NMR is valued rather cheaply.
The Price/Forward Earnings ratio is 8.97, which indicates a very decent valuation of NMR.
NMR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NMR is cheaper than 77.02% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.63. NMR is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.06 | ||
| Fwd PE | 8.97 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NMR is valued a bit cheaper than 67.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 22.69 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.74
EPS Next 2Y0.42%
EPS Next 3Y1.45%
5. Dividend
5.1 Amount
NMR has a Yearly Dividend Yield of 4.70%, which is a nice return.
NMR's Dividend Yield is comparable with the industry average which is at 8.34.
NMR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.7% |
5.2 History
The dividend of NMR is nicely growing with an annual growth rate of 15.59%!
NMR has paid a dividend for at least 10 years, which is a reliable track record.
NMR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)15.59%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
33.03% of the earnings are spent on dividend by NMR. This is a low number and sustainable payout ratio.
NMR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP33.03%
EPS Next 2Y0.42%
EPS Next 3Y1.45%
NYSE:NMR (10/30/2025, 2:52:53 PM)
7.09
+0.02 (+0.28%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners41.49%
Inst Owner Change0.1%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.80B
Revenue(TTM)4736.74B
Net Income(TTM)340.74B
Analysts73.33
Price Target7.73 (9.03%)
Short Float %0.04%
Short Ratio2.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.7% |
Yearly Dividend0.26
Dividend Growth(5Y)15.59%
DP33.03%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.99%
Min EPS beat(2)-10.21%
Max EPS beat(2)58.19%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.08%
EPS NQ rev (1m)-0.19%
EPS NQ rev (3m)0.46%
EPS NY rev (1m)0%
EPS NY rev (3m)2.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1%
Revenue NY rev (3m)-19.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.06 | ||
| Fwd PE | 8.97 | ||
| P/S | 0.67 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.91 | ||
| P/tB | 0.93 | ||
| EV/EBITDA | 22.69 |
EPS(TTM)0.88
EY12.41%
EPS(NY)0.79
Fwd EY11.15%
FCF(TTM)-3.47
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS10.61
BVpS7.78
TBVpS7.61
PEG (NY)N/A
PEG (5Y)0.74
Graham Number12.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.6% | ||
| ROE | 9.82% | ||
| ROCE | 1.65% | ||
| ROIC | 0.63% | ||
| ROICexc | 0.69% | ||
| ROICexgc | 0.7% | ||
| OM | 9.96% | ||
| PM (TTM) | 7.19% | ||
| GM | 39.95% | ||
| FCFM | N/A |
ROA(3y)0.36%
ROA(5y)0.36%
ROE(3y)5.9%
ROE(5y)5.66%
ROIC(3y)0.42%
ROIC(5y)0.41%
ROICexc(3y)0.46%
ROICexc(5y)0.45%
ROICexgc(3y)0.46%
ROICexgc(5y)0.46%
ROCE(3y)1.09%
ROCE(5y)1.09%
ROICexgc growth 3Y16.87%
ROICexgc growth 5Y8.04%
ROICexc growth 3Y16.9%
ROICexc growth 5Y8.08%
OM growth 3Y-11.17%
OM growth 5Y-4.76%
PM growth 3Y-7.1%
PM growth 5Y-8.33%
GM growth 3Y-22.42%
GM growth 5Y-9.54%
F-Score6
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 10.44 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 67.92 | ||
| Cap/Depr | 1410.99% | ||
| Cap/Sales | 18.37% | ||
| Interest Coverage | 0.16 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.22 | ||
| Quick Ratio | 0.22 | ||
| Altman-Z | -0.27 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)988.49%
Cap/Depr(5y)668.06%
Cap/Sales(3y)14.69%
Cap/Sales(5y)11.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.74%
EPS 3Y34.65%
EPS 5Y10.96%
EPS Q2Q%-0.58%
EPS Next Y-2.38%
EPS Next 2Y0.42%
EPS Next 3Y1.45%
EPS Next 5YN/A
Revenue 1Y (TTM)13.94%
Revenue growth 3Y43.77%
Revenue growth 5Y19.39%
Sales Q2Q%-6.17%
Revenue Next Year-22.11%
Revenue Next 2Y-10.98%
Revenue Next 3Y-6.34%
Revenue Next 5YN/A
EBIT growth 1Y72.34%
EBIT growth 3Y27.7%
EBIT growth 5Y13.71%
EBIT Next Year23507.2%
EBIT Next 3Y522.52%
EBIT Next 5YN/A
FCF growth 1Y-122.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-883.38%
OCF growth 3YN/A
OCF growth 5YN/A
NOMURA HOLDINGS INC-SPON ADR / NMR FAQ
Can you provide the ChartMill fundamental rating for NOMURA HOLDINGS INC-SPON ADR?
ChartMill assigns a fundamental rating of 3 / 10 to NMR.
Can you provide the valuation status for NOMURA HOLDINGS INC-SPON ADR?
ChartMill assigns a valuation rating of 4 / 10 to NOMURA HOLDINGS INC-SPON ADR (NMR). This can be considered as Fairly Valued.
What is the profitability of NMR stock?
NOMURA HOLDINGS INC-SPON ADR (NMR) has a profitability rating of 2 / 10.
How financially healthy is NOMURA HOLDINGS INC-SPON ADR?
The financial health rating of NOMURA HOLDINGS INC-SPON ADR (NMR) is 1 / 10.
What is the expected EPS growth for NOMURA HOLDINGS INC-SPON ADR (NMR) stock?
The Earnings per Share (EPS) of NOMURA HOLDINGS INC-SPON ADR (NMR) is expected to decline by -2.38% in the next year.